Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
Top Cited Papers
Open Access
- 1 February 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (7), 5892-5901
- https://doi.org/10.1074/jbc.m404751200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse ModelNeuron, 2004
- Effect of Different Anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force MicroscopyJournal of Molecular Biology, 2004
- Residues 17–20 and 30–35 of beta‐amyloid play critical roles in aggregationJournal of Neuroscience Research, 2003
- The Non-cyclooxygenase Targets of Non-steroidal Anti-inflammatory Drugs, Lipoxygenases, Peroxisome Proliferator-activated Receptor, Inhibitor of κB Kinase, and NFκB, Do Not Reduce Amyloid β42 ProductionOnline Journal of Public Health Informatics, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neuronsExperimental Neurology, 1995
- Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neuronsExperimental Neurology, 1995